<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03564886</url>
  </required_header>
  <id_info>
    <org_study_id>2011296</org_study_id>
    <nct_id>NCT03564886</nct_id>
  </id_info>
  <brief_title>Hyperosmolar Saline Irrigation Fluid in Arthroscopic Knee Surgery</brief_title>
  <acronym>Salty Knee</acronym>
  <official_title>Safety and Efficacy of Hyperosmolar Saline Irrigation Fluid in Arthroscopic Knee Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Missouri-Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Missouri-Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      An isotonic solution, such as saline (0.9%, 300mOsm/L) or lactated ringer's (273 mOsm/L), is&#xD;
      commonly used and safely proven for joint irrigation during arthroscopy. Arthroscopic fluid&#xD;
      is usually pressurized to enable visualization through dilation of the joint or bursa and&#xD;
      prevent bleeding from the microvasculature. It has been recommended that this pressure be&#xD;
      maintained at 49mmHg or less below the systolic blood pressure to preserve the clarity of&#xD;
      view. The combination of large amounts of pressurized irrigation solution and lengthy&#xD;
      arthroscopic procedures may cause substantial tissue fluid retention. Thus, extravasation of&#xD;
      irrigation fluid into the periarticular tissues is inevitable and may create technical&#xD;
      difficulties as well as patient morbidity and complications. Previous investigators have&#xD;
      reported complications including tracheal obstruction, post-operative airway edema and&#xD;
      compromise leading to prolonged intubation, excess weight gain, neurologic injuries, skin&#xD;
      necrosis, and fluid overload associated with excessive fluid extravasation and tissue&#xD;
      retention. Furthermore, it has been shown that fluid accumulated during the operation is&#xD;
      slowly released back into the systemic circulation. Although there is not a rapid change in&#xD;
      circulating volume, there may be implications for elderly patients and those with multiple&#xD;
      comorbidities during prolonged arthroscopic surgery. Therefore the investigators seek to&#xD;
      determine if a hyperosmolar solution, similar to what is used in head trauma patients, can&#xD;
      reduce the degree of fluid extravasation in knee arthroscopy. The investigators also seek to&#xD;
      determine if a hyperosmolar solution has any effect on post-operative knee pain compared to&#xD;
      the standard isotonic solution. The third objective is to determine if a hyperosmolar&#xD;
      solution has any effect on post-operative pain medicine consumption compared to the standard&#xD;
      isotonic solution.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">September 5, 2019</completion_date>
  <primary_completion_date type="Actual">September 5, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fluid Extravasation</measure>
    <time_frame>Immediately Postoperatively</time_frame>
    <description>To determine if a hyperosmolar solution, similar to what is used in head trauma patients, can change the degree of fluid extravasation in knee arthroscopy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative Pain</measure>
    <time_frame>Post-operative Days 1, 2 and 3</time_frame>
    <description>To determine if a hyperosmolar solution has any effect on post-operative knee pain (Visual Analogue Scale; 0-10; 0= no pain; 10= worst pain imaginable) compared to the standard isotonic solution.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid Consumption</measure>
    <time_frame>Postoperative Days 1, 2 and 3.</time_frame>
    <description>To determine if a hyperosmolar solution has any effect on post-operative pain medicine consumption compared to the standard isotonic solution.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Arthroscopic Knee Surgery</condition>
  <arm_group>
    <arm_group_label>Hyperosmolar Saline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The hyperosmolar solution will be created by adding 120cc of 23.4% NS solution to a 3L bag of LR.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Lactate Ringer's (LR, 273mOsm/L) is commonly used at our facility as our isotonic standard irrigation solution and will serve as the control to be evaluated against a hyperosmolar (1.9%, 600mOsm) solution.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyperosmolar Saline</intervention_name>
    <description>The hyperosmolar solution will be created by adding 120cc of 23.4% NS solution to a 3L bag of LR.</description>
    <arm_group_label>Hyperosmolar Saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Lactate Ringer's (LR, 273mOsm/L)</description>
    <arm_group_label>Normal Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients (18 years of age or greater) undergoing arthroscopic knee surgery who&#xD;
             are willing and able to consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current pregnancy or breastfeeding&#xD;
&#xD;
          -  Unable to give consent&#xD;
&#xD;
          -  Prisoner&#xD;
&#xD;
          -  Mentally Disabled&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James P Stannard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Missouri-Columbia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Missouri Health System</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>June 8, 2018</study_first_submitted>
  <study_first_submitted_qc>June 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2018</study_first_posted>
  <results_first_submitted>July 7, 2020</results_first_submitted>
  <results_first_submitted_qc>July 24, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 10, 2020</results_first_posted>
  <last_update_submitted>August 7, 2020</last_update_submitted>
  <last_update_submitted_qc>August 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Missouri-Columbia</investigator_affiliation>
    <investigator_full_name>James Stannard</investigator_full_name>
    <investigator_title>Hansj√∂rg Wyss Distinguished Chair in Orthopaedic Surgery</investigator_title>
  </responsible_party>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 3, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/86/NCT03564886/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Hyperosmolar Saline</title>
          <description>The hyperosmolar solution will be created by adding 120cc of 23.4% NS solution to a 3L bag of LR.&#xD;
Hyperosmolar Saline: The hyperosmolar solution will be created by adding 120cc of 23.4% NS solution to a 3L bag of LR.</description>
        </group>
        <group group_id="P2">
          <title>Normal Saline</title>
          <description>Lactate Ringer's (LR, 273mOsm/L) is commonly used at our facility as our isotonic standard irrigation solution and will serve as the control to be evaluated against a hyperosmolar (1.9%, 600mOsm) solution.&#xD;
Normal saline: Lactate Ringer's (LR, 273mOsm/L)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Hyperosmolar Saline</title>
          <description>The hyperosmolar solution will be created by adding 120cc of 23.4% NS solution to a 3L bag of LR.&#xD;
Hyperosmolar Saline: The hyperosmolar solution will be created by adding 120cc of 23.4% NS solution to a 3L bag of LR.</description>
        </group>
        <group group_id="B2">
          <title>Normal Saline</title>
          <description>Lactate Ringer's (LR, 273mOsm/L) is commonly used at our facility as our isotonic standard irrigation solution and will serve as the control to be evaluated against a hyperosmolar (1.9%, 600mOsm) solution.&#xD;
Normal saline: Lactate Ringer's (LR, 273mOsm/L)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="23"/>
            <count group_id="B2" value="23"/>
            <count group_id="B3" value="46"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="23"/>
                    <count group_id="B3" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.2" spread="12.5"/>
                    <measurement group_id="B2" value="44.0" spread="13.8"/>
                    <measurement group_id="B3" value="42.1" spread="13.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="23"/>
                    <count group_id="B3" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="23"/>
                    <count group_id="B3" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.4" spread="7.1"/>
                    <measurement group_id="B2" value="31.7" spread="6.9"/>
                    <measurement group_id="B3" value="31.0" spread="7.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fluid Extravasation</title>
        <description>To determine if a hyperosmolar solution, similar to what is used in head trauma patients, can change the degree of fluid extravasation in knee arthroscopy.</description>
        <time_frame>Immediately Postoperatively</time_frame>
        <population>Change in Knee Girth (cm)= Postoperative knee girth- preoperative knee girth</population>
        <group_list>
          <group group_id="O1">
            <title>Hyperosmolar Saline</title>
            <description>The hyperosmolar solution will be created by adding 120cc of 23.4% NS solution to a 3L bag of LR.&#xD;
Hyperosmolar Saline: The hyperosmolar solution will be created by adding 120cc of 23.4% NS solution to a 3L bag of LR.</description>
          </group>
          <group group_id="O2">
            <title>Normal Saline</title>
            <description>Lactate Ringer's (LR, 273mOsm/L) is commonly used at our facility as our isotonic standard irrigation solution and will serve as the control to be evaluated against a hyperosmolar (1.9%, 600mOsm) solution.&#xD;
Normal saline: Lactate Ringer's (LR, 273mOsm/L)</description>
          </group>
        </group_list>
        <measure>
          <title>Fluid Extravasation</title>
          <description>To determine if a hyperosmolar solution, similar to what is used in head trauma patients, can change the degree of fluid extravasation in knee arthroscopy.</description>
          <population>Change in Knee Girth (cm)= Postoperative knee girth- preoperative knee girth</population>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="1.1"/>
                    <measurement group_id="O2" value="1.2" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Pain</title>
        <description>To determine if a hyperosmolar solution has any effect on post-operative knee pain (Visual Analogue Scale; 0-10; 0= no pain; 10= worst pain imaginable) compared to the standard isotonic solution.</description>
        <time_frame>Post-operative Days 1, 2 and 3</time_frame>
        <population>Visual Analogue Score (0-10) for the first three postoperative days.</population>
        <group_list>
          <group group_id="O1">
            <title>Hyperosmolar Saline</title>
            <description>The hyperosmolar solution will be created by adding 120cc of 23.4% NS solution to a 3L bag of LR.&#xD;
Hyperosmolar Saline: The hyperosmolar solution will be created by adding 120cc of 23.4% NS solution to a 3L bag of LR.</description>
          </group>
          <group group_id="O2">
            <title>Normal Saline</title>
            <description>Lactate Ringer's (LR, 273mOsm/L) is commonly used at our facility as our isotonic standard irrigation solution and will serve as the control to be evaluated against a hyperosmolar (1.9%, 600mOsm) solution.&#xD;
Normal saline: Lactate Ringer's (LR, 273mOsm/L)</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pain</title>
          <description>To determine if a hyperosmolar solution has any effect on post-operative knee pain (Visual Analogue Scale; 0-10; 0= no pain; 10= worst pain imaginable) compared to the standard isotonic solution.</description>
          <population>Visual Analogue Score (0-10) for the first three postoperative days.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>VAS Pain PostOp Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" spread="2.0"/>
                    <measurement group_id="O2" value="4.8" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS Pain PostOp Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread="1.7"/>
                    <measurement group_id="O2" value="4.8" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS Pain PostOp Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="1.9"/>
                    <measurement group_id="O2" value="3.8" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Opioid Consumption</title>
        <description>To determine if a hyperosmolar solution has any effect on post-operative pain medicine consumption compared to the standard isotonic solution.</description>
        <time_frame>Postoperative Days 1, 2 and 3.</time_frame>
        <population>Pain medication consumption on postoperative days 1, 2, and 3 as measured in morphine equivalent units</population>
        <group_list>
          <group group_id="O1">
            <title>Hyperosmolar Saline</title>
            <description>The hyperosmolar solution will be created by adding 120cc of 23.4% NS solution to a 3L bag of LR.&#xD;
Hyperosmolar Saline: The hyperosmolar solution will be created by adding 120cc of 23.4% NS solution to a 3L bag of LR.</description>
          </group>
          <group group_id="O2">
            <title>Normal Saline</title>
            <description>Lactate Ringer's (LR, 273mOsm/L) is commonly used at our facility as our isotonic standard irrigation solution and will serve as the control to be evaluated against a hyperosmolar (1.9%, 600mOsm) solution.&#xD;
Normal saline: Lactate Ringer's (LR, 273mOsm/L)</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Consumption</title>
          <description>To determine if a hyperosmolar solution has any effect on post-operative pain medicine consumption compared to the standard isotonic solution.</description>
          <population>Pain medication consumption on postoperative days 1, 2, and 3 as measured in morphine equivalent units</population>
          <units>morphine equivalent units</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Medication PostOp Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.0" spread="14.9"/>
                    <measurement group_id="O2" value="23.6" spread="18.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Medication PostOp Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.0" spread="19.7"/>
                    <measurement group_id="O2" value="19.5" spread="18.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Medication PostOp Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="7.6"/>
                    <measurement group_id="O2" value="15.5" spread="17.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 Days</time_frame>
      <desc>A member of the research team was responsible for documenting any perioperative adverse events that occurred prior to discharge. A retrospective review of the electronic medical records was performed to identify any adverse events that occurred within the first 30 days following surgery.</desc>
      <group_list>
        <group group_id="E1">
          <title>Hyperosmolar Saline</title>
          <description>The hyperosmolar solution will be created by adding 120cc of 23.4% NS solution to a 3L bag of LR.&#xD;
Hyperosmolar Saline: The hyperosmolar solution will be created by adding 120cc of 23.4% NS solution to a 3L bag of LR.</description>
        </group>
        <group group_id="E2">
          <title>Normal Saline</title>
          <description>Lactate Ringer's (LR, 273mOsm/L) is commonly used at our facility as our isotonic standard irrigation solution and will serve as the control to be evaluated against a hyperosmolar (1.9%, 600mOsm) solution.&#xD;
Normal saline: Lactate Ringer's (LR, 273mOsm/L)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep Vein Thrombosis (DVT)</sub_title>
                <description>Post-operative DVT</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Lasun Oladeji, MD</name_or_title>
      <organization>University of Missouri, Department of Orthopaedics</organization>
      <phone>573-884-7796</phone>
      <email>OladejiL@health.missouri.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

